vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dýrarannsóknir - lipid breytandi lyf - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)